Drug Profile

Polidocanol - BioForm Medical/Chemische Fabrik Kreussler & Co

Alternative Names: Aethoxysklerol; Asclera

Latest Information Update: 08 Jun 2023

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Chemische Fabrik Kreussler & Co
Class Obesity therapies; Polyethylene glycols; Sclerosants; Small molecules; Vascular disorder therapies
Mechanism of Action Endothelial cell modulators

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Marketed Varicose veins

Most Recent Events

15 Jul 2010 Launched for Varicose veins in USA (IV)
30 Mar 2010 US FDA approves polidocanol injection for the treatment of varicose veins
19 Feb 2010 BioForm Medical has been acquired by Merz Pharma; they are now operating as a wholly-owned subsidiary under the name Merz Aesthetics

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com